Cases 1 - 7 of 7
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. § 1338 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1402
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1405
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Teva Pharmaceuticals USA Inc et al v. Health IQ LLC et al
as 8:2013cv00308
Defendant:
Amgen Canada Inc, Amgen Europe GMBH, Amgen Inc and others
Plaintiff:
Teva Canada Innovation GP-SENC and Teva Pharmaceuticals USA Inc
PIECZENIK v. IDEXX REFERENCE LABORATORIES, INC. et al
as 3:2010cv02327
Plaintiff:
GEORGE PIECZENIK
Defendant:
IDEXX REFERENCE LABORATORIES, INC., ZYMOGENETICS, INC., ZYMOGENETICS, LLC and others
Cause Of Action: 28 U.S.C. § 1338
University of Iowa et al v. Amgen, Inc. et al
as 3:2008cv00112
Plaintiff:
University of Iowa, University of Iowa, University of Iowa and others
Defendant:
Amgen, Inc., Immunex Corporation, Amgen USA Inc. and others
Cause Of Action: Federal Question
Ariad Pharmaceuticals Inc. et al v. Amgen Inc. et al
as 1:2007cv00202
Plaintiff:
Ariad Pharmaceuticals Inc., Massachusetts Institute of Technology, President and Fellows of Harvard College and others
Defendant:
Amgen Inc., Immunex Corporation, Amgen USA Inc. and others
Cause Of Action: 35 U.S.C. § 271 Patent Infringement
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
